Nirad has almost 20 years of management consulting experience, partnering with corporate clients and financial investors to drive results. He has led more than 200 client engagements across the healthcare value chain, including diligence, corporate M&A, transformation, performance improvement and strategy work in the services, payer, provider, medical device and pharmaceuticals sectors.
He has built significant expertise at the intersection of private equity and healthcare and is frequently cited in the media, including appearances on Bloomberg TV, The New York Times, The Wall Street Journal, Reuters, CNBC, Forbes, Buyouts and many others around the globe.
Prior to joining Bain in 2005, Nirad worked for another consulting confirm in New York, where he advised clients on growth and M&A strategies. He also previously worked in the not-for-profit sector.
Nirad holds an MBA from The Wharton School, a Master of Science from Stanford University and a Bachelor of Science, with honors, from Columbia University.
- “Heady Competition for Healthcare Assets May Change the Route to Returns,” The PE Hub Network, 24. April 2019, Artikel
- “Letter from Kara Murphy and Nirad Jain,” Report, 17. April 2019
- “Year in Review: Mega-Deals im Gesundheitssektor weisen die Richtung,” Report, 17. April 2019
- “Getting Healthcare Deals Done in a Crowded Market,” Report, 17. April 2019
- “North America: Ample Capital Pushes Deal Activity to Record Levels,” Report, 17. April 2019
- “Europe: Robust Activity Despite Long-Term Uncertainty,” Report, 17. April 2019
- “Asia-Pacific: Surging Consumer Demand for Healthcare,” Report, 17. April 2019
- “Providers: A Push into New Segments,” Report, 17. April 2019
- “Payers: Assets that Help Increase Operational Efficiencies,” Report, 17. April 2019
- “Biopharma: Strong Activity in the Face of Regulatory and Pricing Pressures,” Report, 17. April 2019